trial
as of 2026-07-01The Impact of Aripiprazole Long-acting on Myelin and Cognition in the Onset of Schizophrenia
NCTId NCT05322031
at a glance
Phase 4 · Completed
Enrollment 15 (actual)
Primary completion 2024-08-31
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
15 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2022-08-01
Primary completion
2024-08-31
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
Investigators
2
Paolo Brambilla, ProfessorStudy Chair
Massimo C Mauri, ProfessorStudy Director
Sites
1 total
Milan, Italy
Facts & assertions
4 sourced
Enrollment
15
Phase
PHASE4
Primary Completion Date
2024-08-31
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
indication
investigator